Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 310

Results For "live"

3625 News Found

IMI releases tamper evident caps with DoseID certified RFID
Digitisation | February 26, 2022

IMI releases tamper evident caps with DoseID certified RFID

Tamper evident caps with incorporated RFID technology offer a significant reduction in RFID implementation costs


Jean-Luc Herbeaux to become Hovione CEO
People | February 26, 2022

Jean-Luc Herbeaux to become Hovione CEO

Guy Villax was also involved with the EFCG and Rx-360 associations and contributed to legislation being passed on both sides of the Atlantic to fight fake medicines and to level the playing field for GMP manufacturing.


Wockhardt Hospitals, Mira Road opens centre for sports medicine
Hospitals | February 25, 2022

Wockhardt Hospitals, Mira Road opens centre for sports medicine

The facility is spread across 215000 sq. feet and provides super-speciality care


USFDA grants Breakthrough Therapy Designation for Idiopathic Pulmonary Fibrosis therapy
Biotech | February 25, 2022

USFDA grants Breakthrough Therapy Designation for Idiopathic Pulmonary Fibrosis therapy

Boehringer Ingelheim plans to study this novel investigational therapy in patients with progressive fibrosing interstitial lung diseases


Actu-Real and Jehangir Clinical Dev Centre announce strategic collaboration
Biotech | February 25, 2022

Actu-Real and Jehangir Clinical Dev Centre announce strategic collaboration

The joint initiative is called J-ARC Healthcare Solutions


GliaPharm SA collaborate with Wyss Centre for Alzheimer therapy
Biotech | February 25, 2022

GliaPharm SA collaborate with Wyss Centre for Alzheimer therapy

The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers


UK Vaccine Network funding for ConserV pan-coronavirus project
News | February 25, 2022

UK Vaccine Network funding for ConserV pan-coronavirus project

UNICOR-v has the potential to protect against future epidemics caused by a coronavirus jumping from animals to humans, but also against new variants emerging from SARS-Cov-2


Biohaven licenses Taldefgrobep Alfa from Bristol Myers Squibb
Biotech | February 25, 2022

Biohaven licenses Taldefgrobep Alfa from Bristol Myers Squibb

It is a Phase 3 ready anti-myostatin adnectin for Spinal Muscular Atrophy (SMA).


Sanofi and GSK to seek regulatory authorization for Covid-19 vaccine
News | February 24, 2022

Sanofi and GSK to seek regulatory authorization for Covid-19 vaccine

100% efficacy against severe Covid-19 disease and hospitalizations


Elanco announces appointment of Rajeev (Bobby), Modi as Executive VP, U.S. Pet Health
People | February 24, 2022

Elanco announces appointment of Rajeev (Bobby), Modi as Executive VP, U.S. Pet Health

Modi holds a bachelor's degree in Chemical Engineering from University of Cincinnati and a master’s degree in Marketing, Management Strategy and Finance from Northwestern’s Kellogg School of Management